{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:26:59Z","timestamp":1790263619593,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s00508-012-0162-9","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T08:48:45Z","timestamp":1335257325000},"page":"251-255","source":"Crossref","is-referenced-by-count":12,"title":["Assessment of metabolic syndrome in patients with primary biliary cirrhosis","Erfassung des metabolischen Syndroms bei Patienten mit prim\u00e4r bili\u00e4rer Leberzirrhose"],"prefix":"10.1007","volume":"124","author":[{"given":"Tamara","family":"Alempijevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Sokic-Milutinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Pavlovic Markovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rada","family":"Jesic-Vukicevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biljana","family":"Milicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djuro","family":"Macut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Tomic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,25]]},"reference":[{"key":"162_CR1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353:1261\u201373.","journal-title":"N Engl J Med"},{"key":"162_CR2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/00365529709025067","volume":"32","author":"GM Van Dam","year":"1997","unstructured":"Van Dam GM, Gips CH. Primary biliary cirrhosis in The Netherlands. An analysis of associated diseases, cardiovascular risk, and malignancies on the basis of mortality figures. Scand J Gastroenterol. 1997;32:77\u201383.","journal-title":"Scand J Gastroenterol"},{"key":"162_CR3","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.1840150518","volume":"15","author":"JS Crippin","year":"1992","unstructured":"Crippin JS, Lindor KD, Jorgensen R, et al. Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk? Hepatology. 1992;15:858\u201362.","journal-title":"Hepatology"},{"issue":"11","key":"162_CR4","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1872-034X.2010.00717.x","volume":"40","author":"WJ Cash","year":"2010","unstructured":"Cash WJ, McCance DR, Young IS, et al. Primary biliary cirrhosis is associated with oxidative stress and endothelial dysfunction but not increased cardiovascular risk. Hepatol Res. 2010;40(11):1098\u2013106.","journal-title":"Hepatol Res"},{"key":"162_CR5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.atherosclerosis.2006.11.036","volume":"194","author":"A Sorokin","year":"2007","unstructured":"Sorokin A, Brown JL, Thompson PD. Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review. Atherosclerosis. 2007;194:293\u20139.","journal-title":"Atherosclerosis"},{"key":"162_CR6","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1136\/gut.2005.079814","volume":"55","author":"M Allocca","year":"2006","unstructured":"Allocca M, Crosignani A, Gritti A, et al. Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis. Gut. 2006;55:1795\u2013800.","journal-title":"Gut"},{"key":"162_CR7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/gut.51.2.265","volume":"51","author":"M Longo","year":"2002","unstructured":"Longo M, Crosignani A, Battezzati PM, et al. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut. 2002;51:265\u20139.","journal-title":"Gut"},{"issue":"3","key":"162_CR8","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.21741","volume":"46","author":"T Stojakovic","year":"2007","unstructured":"Stojakovic T, Putz-Bankuti C, Fauler G, et al. Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid. Hepatology. 2007;46(3):776\u201384.","journal-title":"Hepatology"},{"issue":"1","key":"162_CR9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.atherosclerosis.2009.08.052","volume":"209","author":"T Stojakovic","year":"2010","unstructured":"Stojakovic T, Claudel T, Putz-Bankuti C, et al. Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment. Atherosclerosis. 2010;209(1):178\u201383.","journal-title":"Atherosclerosis"},{"key":"162_CR10","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an AmericanHeart Association\/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735\u201352.","journal-title":"Circulation"},{"key":"162_CR11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KG Alberti","year":"2006","unstructured":"Alberti KG, Zimmet P, Shaw J. Metabolic syndrome\u2014a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469\u201380.","journal-title":"Diabet Med"},{"key":"162_CR12","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/ajcn\/78.5.902","volume":"78","author":"J Wang","year":"2003","unstructured":"Wang J. Waist circumference: a simple, inexpensive, and reliable tool that should be included as part of physical examinations in the doctor\u2019s office. Am J Clin Nutr. 2003;78:902\u20133.","journal-title":"Am J Clin Nutr"},{"key":"162_CR13","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.metabol.2005.04.009","volume":"54","author":"E Merino-Ibarra","year":"2005","unstructured":"Merino-Ibarra E, Artieda M, Cenarro A, et al. Ultrasonography for the evaluation of visceral fat and the metabolic syndrome. Metab Clin Exp. 2005;54:1230\u20135.","journal-title":"Metab Clin Exp"},{"issue":"8","key":"162_CR14","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2169\/internalmedicine.44.794","volume":"44","author":"M Hirooka","year":"2005","unstructured":"Hirooka M, Kumagi T, Kurose K, et al. A technique for the measurement of visceral fat by ultrasonography: comparison of measurements by ultrasonography and computed tomography. Intern Med. 2005;44(8):794\u20139.","journal-title":"Intern Med"},{"key":"162_CR15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, et al. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u20139.","journal-title":"Diabetologia"},{"issue":"11","key":"162_CR16","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1111\/j.1572-0241.2008.02092.x","volume":"103","author":"M Solaymani-Dodaran","year":"2008","unstructured":"Solaymani-Dodaran M, Aithal GP, Card T, West J. Risk of cardiovascular and cerebrovascular events in primary biliary cirrhosis: a population-based cohort study. Am J Gastroenterol. 2008;103(11):2784\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"162_CR17","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1572-0241.2008.01888.x","volume":"103","author":"A Floreani","year":"2008","unstructured":"Floreani A, Variola A, Niro G, et al. Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis. Am J Gastroenterol. 2008;103(8):1959\u201365.","journal-title":"Am J Gastroenterol"},{"key":"162_CR18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/07853890802004959","volume":"40","author":"JP Despres","year":"2008","unstructured":"Despres JP, Cartier A, C\u00f4t\u00e9 M, Arsenault BJ. The concept of cardiometabolic risk: bridging the fields of diabetology and cardiology. Ann Med. 2008;40:514\u201323.","journal-title":"Ann Med"},{"key":"162_CR19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4158\/EP09340.RA","volume":"16","author":"MZ Allende-Vigo","year":"2010","unstructured":"Allende-Vigo MZ. Pathophysiologic mechanisms linking adipose tissue and cardiometabolic risk. Endocr Pract. 2010;16:692\u20138.","journal-title":"Endocr Pract"},{"key":"162_CR20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1043-2760(00)00301-5","volume":"10","author":"RS Ahima","year":"2000","unstructured":"Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocriol Metab. 2000;10:327\u201332.","journal-title":"Trends Endocriol Metab"},{"key":"162_CR21","first-page":"160","volume":"61","author":"M Gnaci\u0144ska","year":"2010","unstructured":"Gnaci\u0144ska M, Ma\u0142gorzewicz S, Guzek M, Lysiak-Szyd\u0142owska W, Sworczak K. Adipose tissue activity in relation to overweight or obesity. Endokrynol Pol. 2010;61:160\u20138.","journal-title":"Endokrynol Pol"},{"issue":"7","key":"162_CR22","first-page":"19","volume":"60","author":"L Duvnjak","year":"2009","unstructured":"Duvnjak L, Duvnjak M. The metabolic syndrome\u2014an ongoing story. J Physiol Pharmacol. 2009;60(7):19\u201324.","journal-title":"J Physiol Pharmacol"},{"key":"162_CR23","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.febslet.2006.04.028","volume":"580","author":"Y. Matsuzawa","year":"2006","unstructured":"Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett. 2006;580:2917\u201321.","journal-title":"FEBS Lett"},{"key":"162_CR24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1042\/CS20100008","volume":"119","author":"ML Balmer","year":"2010","unstructured":"Balmer ML, Joneli J, Schoepfer A, Stickel F, Thormann W, Dufour JF. Significance of serum adiponectin levels in patients with chronic liver disease. Clin Sci (Lond). 2010;119:431\u20136.","journal-title":"Clin Sci (Lond)"},{"key":"162_CR25","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2004.12.024","volume":"42","author":"F Tacke","year":"2005","unstructured":"Tacke F, W\u00fcstefeld T, Horn R, et al. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo. J Hepatol. 2005;42:666\u201373.","journal-title":"J Hepatol"},{"key":"162_CR26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI200317797","volume":"112","author":"A Xu","year":"2003","unstructured":"Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest. 2003;112:91\u2013100.","journal-title":"J Clin Invest"},{"key":"162_CR27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00042737-200602000-00010","volume":"18","author":"C Aygun","year":"2006","unstructured":"Aygun C, Senturk O, Hulagu S, et al. Serum levels of hepatoprotective peptide adiponectin in non-alcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2006;18:175\u201380.","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-012-0162-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-012-0162-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-012-0162-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T19:52:09Z","timestamp":1561665129000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-012-0162-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":27,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["162"],"URL":"https:\/\/doi.org\/10.1007\/s00508-012-0162-9","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}